Sigilon Therapeutics sigilon.com


Public lists: Pharma Startups (4524)

Sigilon Therapeutics discovers and develops category-defining biocompatible encapsulated cell therapies. Sigilon Therapeutics' discovery platform combines cell engineering and biocompatible Afibromerâ„¢ technology, a new class of implantable biomaterials that do not trigger fibrosis. The company will develop products that emerge from its discovery platform to treat serious hematologic, enzyme deficiency and endocrine disorders.

Sigilon Therapeutics discovers and develops category-defining biocompatible encapsulated cell therapies. Sigilon Therapeutics' discovery platform combines cell engineering and biocompatible Afibromerâ„¢ technology, a new class of implantable biomater...Show all

Company (Alive / Active)

Phone: 617-336-7540

Fax:

161 First Street
Suite 2C
Cambridge, 0214
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Sigilon Therapeutics $23.5M Jun 21, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Sigilon Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)